An expression meta-analysis of predicted microRNA targets identifies a diagnostic signature for lung cancer
2008

Identifying a Gene Signature for Lung Cancer Diagnosis

Sample size: 354 publication 10 minutes Evidence: high

Author Information

Author(s): Liang Yu

Primary Institution: Applied Biosystems

Hypothesis

Can a set of predicted microRNA target genes distinguish between lung adenocarcinoma and squamous cell carcinoma?

Conclusion

The study identifies a 17-gene signature that can effectively predict lung cancer subtypes and improve diagnostic accuracy.

Supporting Evidence

  • Expression of the 17-gene signature predicted 87% of adenocarcinoma and 82% of squamous cell carcinoma cases.
  • The gene signature showed 89-90% sensitivity for lung cancer detection when combined with cytopathology.
  • Independent datasets confirmed the predictive power of the 17-gene signature for lung cancer subtypes.

Takeaway

Researchers found a group of 17 genes that can help doctors tell if someone has lung cancer, making it easier to diagnose and treat patients.

Methodology

The study used computational predictions of miRNA target genes, followed by meta-analysis of microarray data from multiple datasets.

Potential Biases

Potential bias in dataset selection and gene expression variability across different populations.

Limitations

The study may not account for all potential confounding factors in gene expression across different datasets.

Participant Demographics

The study included samples from patients with lung adenocarcinoma and squamous cell carcinoma.

Statistical Information

P-Value

0.004

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1755-8794-1-61

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication